CP
This biotechnology company utilizes its expertise in preclinical and clinical pharmacology, biostatistics, and regulatory affairs to expedite drug development for various diseases. By streamlining the process, it enables healthcare professionals to access essential therapies that meet significant medical needs.
Updated 3 months ago
Funding
$176M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This biotechnology company utilizes its expertise in preclinical and clinical pharmacology, biostatistics, and regulatory affairs to expedite drug development for various diseases. By streamlining the process, it enables healthcare professionals to access essential therapies that meet significant medical needs.